Key Segmentation:
By Indication
-
Degenerative Sacroiliitis
-
Sacral Disruption
-
Trauma
By Treatment Type
-
Surgery
-
Injections
-
Radiofrequency Ablation
By Surgical Approach
-
Lateral Transiliac
-
Posterior/Dorsal
-
Anterior
By Product
-
Implants
-
Instruments & Accessories
By End User
-
Hospitals
-
Ambulatory Surgical Centers
-
Other End Users
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Indication X End User)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
Key players include SI-BONE, Inc., Medtronic plc, Globus Medical, Inc., Orthofix Medical Inc., and SIGNUS Medizintechnik GmbH, among others.
Key opportunities include pelvic trauma and fragility fracture fixation, sacropelvic fixation in adult deformity surgery, ambulatory procedure growth, and international market expansion.
The primary growth factor is the rising prevalence of chronic lower back pain and sacroiliac joint dysfunction, combined with growing adoption of minimally invasive fusion techniques.
By indication, the Degenerative Sacroiliitis segment dominates the Sacroiliac Joint Fusion Market with approximately 38.42% share in 2025.
North America dominates the Sacroiliac Joint Fusion Market with approximately 41.64% share in 2025.
